Constrictive pericarditis (CP) after allogeneic SCT may develop after infective pericarditis or pericardial GVHD. Primary effusion lymphoma (PEL), also a rare disease, is usually seen in immunocompromised patients and has a poor prognosis.
Constrictive pericarditis (CP) after allogeneic SCT may develop after infective pericarditis or pericardial GVHD. Primary effusion lymphoma (PEL), also a rare disease, is usually seen in immunocompromised patients and has a poor prognosis.
We describe a case of CP and PEL developing in a patient after allo-SCT for CML. We believe it is the first documented case of these complications in this setting, and include rare FDG-PET images of PEL.
A 42-year-old Italian-born man underwent a sibling allograft in 1987 for CML in chronic phase. Myeloablative conditioning was given with CY (60 mg/kg on days À6 and À5) and TBI (2 cGy twice daily on days À4, À3 and À2); complete donor engraftment ensued, with complete cytogenetic remission. Moderately severe chronic GVHD involving skin, oral mucosa, eyes and liver was treated with CYA, prednisolone and PUVA treatment before thalidomide was commenced, with good effect.
Twenty-four months post allograft there were no other manifestations of GVHD, but he developed symptoms of pericarditis including chest pain, fever, tachycardia, hypotension and raised inflammatory markers. The electrocardiogram showed widespread ST elevation without elevation of creatine kinase MB, and chest X-ray showed a large pericardial effusion. No infective or autoimmune cause was identified and he improved with symptomatic management. Thalidomide was ceased, with no obvious immediate recurrence of GVHD.
At subsequent follow --up the patient was hypotensive and complained of lethargy, dizziness and general malaise. After 6 months he developed right upper quadrant pain and abnormal liver function tests (LFTs), with alkaline phosphatase (ALP) 250 U/L (20 --175 U/L), gamma-glutamyl transferase (GGT) 550 U/L (o45 U/L) and normal transaminases and bilirubin. Ultrasound showed no cholelithiasis; liver biopsy demonstrated micronodular cirrhosis with no other specific features. Some months later, he developed ascites and peripheral oedema, managed with diuretic therapy. Symptoms and signs of chronic liver disease persisted for the next 20 years and were attributed to chronic hepatic GVHD. Cortisone acetate 37.5 mg daily caused marked improvement in appetite, energy and well being (although no improvement in LFTs), and was therefore continued despite normal adrenocorticotropic hormone levels.
In 2010, 23 years post transplant, the patient deteriorated rapidly over 3 months. He was admitted to hospital with extreme lethargy, nausea, 10-kg weight loss and worsening ascites, peripheral oedema and hypotension, which did not respond to medical management.
On examination he was hypotensive (systolic blood pressure 85 mm Hg), with a sinus tachycardia (100 b.p.m.) and elevated jugular venous pressure (9 cm). He had small pleural effusions, marked ascites and peripheral oedema to the groin. He was afebrile without palpable lymphadenopathy or hepatosplenomegaly.
He leading to weight loss were likely due to ascites and bowel oedema, in turn attributable to severe right-heart failure secondary to CP. The decision was therefore made to proceed with pericardiectomy, despite his poor pre-operative nutritional and functional status.
Meanwhile, ascitic fluid analysis detected a population of atypical lymphoid cells, as seen in Figure 1 . Immunohistochemical stains were positive for CD 45 and CD 138, but negative for TdT, CD34, MPO, CD3, CD5, CD20, CD79, CD30 and ALK 1. The Ki67 index was 100%. Human herpes virus-8 (HHV-8) was detected in the ascitic fluid using PCR. The constellation of ascites, atypical lymphoid cells and positivity for HHV-8 suggested a diagnosis of PEL. The patient had a positron emission tomography scan (Figure 2) prior to urgent pericardiectomy.
Despite initial improvement in cardiac function postoperatively, the patient required increasing inotropic support and died in the intensive care unit 2 weeks later. A trial of high-dose steroid therapy during this time caused no discernable improvement. Staining of the atypical lymphoid cells for latency-associated nuclear Ag (LANA1) was undertaken posthumously (Figure 1b) , providing confirmation of HHV-8 in the lymphoma cells and a definitive diagnosis of PEL.
Pericarditis, most likely due to GVHD and/or viral pericarditis, evolved to CP in our patient. We suggest all BMT patients with pericarditis or pericardial effusion be evaluated regularly (perhaps with biannual echocardiograms) for the development of CP. Surgical management offers the best hope of symptomatic and functional improvement, with long-term survival related to the underlying aetiology. 1 PEL is usually seen in HIV-positive patients, but has been described in other immunosuppressed patient populations and elderly men of Mediterranean origin. 2, 3 Prior infection with HHV-8 is necessary for pathogenesis, and its demonstration in lymphoma cells is required for diagnosis. PEL presents as a lymphomatous effusion in a body cavity, usually without an associated tissue mass. Malignant cells display no specific B-or T-cell markers, but usually show markers of lymphocyte activation (CD30, CD38 and HLA-DR) and plasma cell differentiation (CD138). 2 The outlook is generally poor even with treatment, with median survival of 6.2 months and few long-term survivors. 4 In our case, the rapid clinical deterioration after years of stable chronic liver disease was a clue to the development of an aggressive lymphoma. Clinicians should be mindful of this rare diagnosis in cases of severe or intractable serous effusions in immunocompromised patients. 
